focus -WSS

focus

author：hotspot 2025-09-06 01:58:36 - browse：6388

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

leisure time

WSS

Structure Therapeutics oral GLP

Medicare Advantage's lean provider networks lead CMS complaints

Petition to FDA: Get the lead out of consumer hair dyes

STAT wants to know your pick for a great summer read or listen

'Little Tech' descents on D.C., wanting a say in how AI is regulated

FDA approves Moderna’s RSV vaccine, its second licensed product

hotspot

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Trump demands the U.S. pay no more for drugs than other countries … again

Lecanemab for Alzheimer's is coming. Is the health system ready?

Drug repurposing or repositioning? The language matters

Lecanemab for Alzheimer's is coming. Is the health system ready?

Medicare details structure of new drug price negotiation program

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

United colonoscopy coverage change 'may cost lives,' doctors say

Charles Manson follower Leslie Van Houten released from prison after 53 years

explore

Structure Therapeutics oral GLP

FTC loses bid to block Novant's North Carolina hospital merger

'Little Tech' descents on D.C., wanting a say in how AI is regulated

How CO2 helps viruses stay alive longer in the air

Charles Manson follower Leslie Van Houten released from prison after 53 years

N.Y. state detects polio case, first in the U.S. since 2013

hotspot

entertainment

leisure time

entertainment